Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan Robert Hunt currently holds 59,800 shares of Perspective Therapeutics, Inc. (CATX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Robert Hunt has been a net buyer of CATX stock. They have purchased $186.1K and sold $0 worth of shares.
Jonathan Robert Hunt's most recent insider trade was on Nov 13, 2025, when they purchased 11,000 shares at $2.03 per share.
Jonathan Robert Hunt serves as Executive at Perspective Therapeutics, Inc. (CATX). They have executed 11 insider transactions totaling $186.1K over their tenure at the company.
Jonathan Robert Hunt holds the position of Executive at Perspective Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Jonathan Robert Hunt has shown a buying trading pattern, with $186.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jonathan Robert Hunt was on Oct 22, 2020, when they purchased $35.0K worth of ISR shares. This transaction involved 67,306 shares at $0.52 per share.
Jonathan Robert Hunt currently owns 59,800 shares of Perspective Therapeutics, Inc. (CATX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan Robert Hunt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan Robert Hunt has 11 Form 4 filings on record as an insider at Perspective Therapeutics, Inc..
Set alerts for Jonathan Robert Hunt and 40,000+ other insiders.